Suppose that gene therapy could be used to lower levels ofcholesterol and saturated fat in the blood, thus allowing people toconsume fat-rich fried foods with little risk of heart disease.However, this treatment might not work for everyone, and therewould be no way of knowing in advance who would benefit. As aresult, some people would inevitably die prematurely from heartdisease. Should such gene therapy be approved for use in humans?Answer this question by briefly describing how a bioethicist whobelieves in a utilitarian approach might view this scenario, andcontrast this perspective with a deontological viewpoint.
